A. H. EROĞLU Et Al. , "The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients," Experimental Oncology , vol.38, no.3, pp.187-190, 2016
EROĞLU, A. H. Et Al. 2016. The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients. Experimental Oncology , vol.38, no.3 , 187-190.
EROĞLU, A. H., Ceylan, G., ÖZTÜRK, E., YALÇIN, A., YALÇIN, B., & KARASOY, D., (2016). The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients. Experimental Oncology , vol.38, no.3, 187-190.
EROĞLU, AHMET Et Al. "The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients," Experimental Oncology , vol.38, no.3, 187-190, 2016
EROĞLU, AHMET H. Et Al. "The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients." Experimental Oncology , vol.38, no.3, pp.187-190, 2016
EROĞLU, A. H. Et Al. (2016) . "The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients." Experimental Oncology , vol.38, no.3, pp.187-190.
@article{article, author={AHMET HİKMET EROĞLU Et Al. }, title={The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients}, journal={Experimental Oncology}, year=2016, pages={187-190} }